ASPIRIN CURES ERYTHROMELALGIA AND CEREBROVASCULAR DISTURBANCES IN JAK2-THROMBOCYTHEMIA THROUGH PLATELET-CYCLOXYGENASE INHIBITION – MPN Research Foundation
Skip to content
MPN Research Foundation
Search for...
Menu
RESEARCH
Research Impact
MPN Challenge™
MPN Roundtable™
Patient-Focused Drug Development
2022 Thrive Initiative
MPN Interferon Initiative
Apply For Research Funding
PATIENTS & CAREGIVERS
MPN Clinical Trials
Patient & Caregiver Stories
Patient & Caregiver Resources
Living with an MPN
Find Support
UNDERSTANDING MPNS
Essential Thrombocythemia (ET)
Polycythemia Vera (PV)
Myelofibrosis (MF)
30 Facts about MPNs
Glossary
SUPPORT US
Make a Donation
Other Ways to Give
Create Your Own Fundraiser
ABOUT MPNRF
Our Mission & History
Board of Directors
Our Team
Scientific Advisory Board
News & Articles
Newsletters
Our Partners
DONATE
JOIN COMMUNITY
ASPIRIN CURES ERYTHROMELALGIA AND CEREBROVASCULAR DISTURBANCES IN JAK2-THROMBOCYTHEMIA THROUGH PLATELET-CYCLOXYGENASE INHIBITION
To view the Abstract pg this article please click
here.
Receive updates on the latest MPN news & events.
SIGN UP TODAY
Find out ways you can help support MPN patients and researchers.
MAKE AN IMPACT
MPNRF Team
Board of Directors
About MPNRF
Our Mission and History